Research Study

Safety Study of Etripamil Nasal Spray for Patients With Paroxysmal Supraventricular Tachycardia
Principal Investigator 
Matthew Bennett

Overview

Body Locations and Systems 
Arrhythmia
ClinicalTrials.gov# 
NCT04072835
Status 
Recruiting
Study Start/End 
Oct 27, 2020 to Sep 8, 2021
Name/Title 
Matthew Wei
Phone 
604-875-5104
Email Address 
Matthew.Wei@vch.ca
Purpose of Study 

The purpose of this study is to evaluate the safety of etripamil nasal spray in patients with Paroxysmal Supraventricular Tachycardia (PSVT).

Eligibility 

Visit ClinicalTrials.gov for more information

Disclaimer 

Study Coordinators and Research Nurses cannot give medical advice over the phone. Telephone numbers and email addresses are provided for obtaining additional information on specific research studies only. If you have specific questions which require clinical expertise, please call your primary care physician.